Unichem Laboratories — 360° view

Unichem Laboratories, a company in the Pharmaceuticals industry, reported revenue of ₹640 crore and net profit of ₹22 crore for the September 2026 quarter.

Unichem Laboratories (NSE: UNICHEMLAB) closed at ₹468.95 on 20 Nov 2026, down 1.9% over the past year. Its market capitalisation is ₹3,302 crore and it trades at 27.8 times earnings.

Share price
₹468.95 (20 Nov 2026)
Market cap
₹3,302 Cr (20 Nov 2026)
P/E
27.78 (20 Nov 2026)
Revenue
₹640 Cr (September 2026 quarter)
Net profit
₹22 Cr (September 2026 quarter)
ROCE
4.13% (FY26)
ROE
3.17% (FY26)
Book value
₹395 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹687.20 / ₹278.20 (20 Nov 2026)
1-year return
-1.9% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: UNICHEMLAB

Unichem Laboratories Ltd is involved in pharmaceuticals in Generics, APIs and Contract Manufacturing (CMO) areas.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.